HUTCHMED (China) (HCM) Operating Margin (2015 - 2021)
HUTCHMED (China) (HCM) posted quarterly Operating Margin of 278.72% for Q1 2021, up 443.0% year-over-year from 51.33% in Q1 2020, and up 104.89% quarter-over-quarter from 136.04% in Q2 2020.
HUTCHMED (China) (HCM) Operating Margin (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Operating Margin for 6 consecutive years, with 278.72% the latest figure, recorded in Q1 2021.
- In Q1 2021, Operating Margin rose 443.0% year-over-year to 278.72%; the TTM figure through Mar 2021 stood at 167.76% (up 18782.0% YoY), while the FY2025 annual figure was 55.53%, up 229294.0% from the prior year.
- Operating Margin advanced to 278.72% in Q1 2021 per HCM's latest filing, from 136.04% in the prior quarter.
- Across five years, Operating Margin topped out at 278.72% in Q1 2021 and bottomed at 303.37% in Q4 2018.
- Historically, Operating Margin has averaged 20.83% across 4 years, with a median of 25.14% in 2018.
- Annual changes were most pronounced in 2019 — Operating Margin tumbled 37387 bps — and 2020, when it jumped 35203 bps.
- HUTCHMED (China)'s Operating Margin stood at 303.37% in 2018, then surged by 76 bps to 72.05% in 2019, then surged by 289 bps to 136.04% in 2020, then soared by 105 bps to 278.72% in 2021.
- Business Quant data shows HCM's Operating Margin at 278.72% in Q1 2021, 136.04% in Q2 2020, and 274.29% in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 278.72% |
| Jun 30, 2020 | 136.04% |
| Mar 31, 2020 | 274.29% |
| Dec 31, 2019 | -72.05% |
| Sep 30, 2019 | -72.83% |
| Jun 30, 2019 | -216.00% |
| Mar 31, 2019 | 69.10% |
| Dec 31, 2018 | -303.37% |
| Sep 30, 2018 | 25.14% |
| Jun 30, 2018 | 157.88% |
| Mar 31, 2018 | -47.81% |
| Jun 30, 2016 | 71.54% |
| Jun 30, 2015 | 59.24% |